General form of registration statement for all companies including face-amount certificate companies

Note 13 - Research and Development Expenses

v3.24.3
Note 13 - Research and Development Expenses
6 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2023
Notes to Financial Statements    
Research, Development, and Computer Software Disclosure [Text Block]

NOTE 13: RESEARCH AND DEVELOPMENT EXPENSES

 

   

Three months ended

June 30,

   

Six months ended

June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Salary and employee benefits

  $ 210     $ 167     $ 443     $ 254  

Consultants and subcontractors

    70       17       77       23  

Depreciation and amortization

    4       -       4       -  

Clinical trials

    -       14       -       19  

Expenses - other

    66       1       115       24  
      350       199       639       320  

Less – grants received

    -       -       -       -  

Total

  $ 350     $ 199     $ 639     $ 320  

  

NOTE 15: RESEARCH AND DEVELOPMENT EXPENSES

 

   

December 31

 
   

2023

   

2022

 
                 

Salary and employee benefits

  $ 527     $ 944  

Consultants and subcontractors

    99       152  

Depreciation and amortization

    -       14  

Clinical trials

    3       60  

Expenses - other

    112       129  
      741       1,299  

Less – grants received

    -       -  

Total

  $ 741     $ 1,299